Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

CHOEP + High Dose Therapy + Auto SCT for T-Cell Lymphoma

This study has been terminated.
(Slow accrual and futility)
Massachusetts General Hospital
Beth Israel Deaconess Medical Center
Information provided by (Responsible Party):
Philippe Armand, MD, PhD, Dana-Farber Cancer Institute Identifier:
First received: December 4, 2012
Last updated: August 7, 2015
Last verified: August 2015
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Study Completion Date: June 2015
  Primary Completion Date: June 2015 (Final data collection date for primary outcome measure)